Contact Lens Prescription Verification Modernization Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Contact Lens Prescription Verification Modernization Act This bill revises the requirements for the verification of prescriptions related to the purchase of contact lenses. Specifically, online sellers of prescription contact lenses must provide consumers with a method to transmit a digital copy of their prescriptions to such sellers. Online sellers also must encrypt protected health information they send by email. Additionally, the bill prohibits any seller of prescription contact lenses from using telephone calls with an artificial or prerecorded voice (i.e., robocalls) to verify a consumer's prescription.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Referred to the Subcommittee on Consumer Protection and Commerce.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · fourth_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes. S. 1793 / HR 3461 - The Dental and Optometric Care Access Act (DOC Access Act). This will amend title XXVII of the Public Health Service Act to improve health care coverage under vision and dental plans and for other purposes.
Client expense: $660,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
P.L. 111-148 Affordable Care Act, modifications Prior authorization utilization policies Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Medicare Physician Payment Reform Issues Medicare sequestration cuts Drug Pricing and Shortages Issues Medicare Part B Drug Price Issues Expansion of Telehealth Services Vision Research Funding Implementation of No Surprise Act HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act HR 2163/S 464, Safe Step Act HR 1916/S 754, Ensuring Lasting Smiles Act Medicare Coverage for Low Vision Devices HR 4187, the Medicare Vision Act HR 869/S 289, Research Investment to Spark the Economy (RISE) Act HR 366, Protecting Access to Post-COVID 19 Telehealth Act HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 HR 3353, the Contact Lens Prescription Verification Modernization Act HR4122, Resident Education Deferred Interest (REDI) Act HR 5376, the Build Back Better Act HR 6000, Cures 2.0 Act S. 4333, the CLEAR Act S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act
Client expense: $406,636 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
Client expense: $2,270,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act S. 4293, the Pharmacy Benefit Manager Transparency Act. H.R. _, the Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies Funding Bill Notice Of Proposed Rulemaking (NPRM) On The Affordability Of Employer Coverage For Family Members Of Employees H.R. 7504, the Start-ups for Cures Act H.R. 7505, the More Cures Act
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
HR 3353 HR 3461 Optometric Subjects of Contact Lens Prescription and Vision Plans
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HR 3353 HR3461 S1784
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act S. 4293, the Pharmacy Benefit Manager Transparency Act. H.R. _, the Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies Funding Bill Notice Of Proposed Rulemaking (NPRM) On The Affordability Of Employer Coverage For Family Members Of Employees H.R. 7504, the Start-ups for Cures Act H.R. 7505, the More Cures Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
P.L. 111-148 Affordable Care Act, modifications Prior authorization utilization policies Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Medicare Physician Payment Reform Issues Medicare sequestration cuts Drug Pricing and Shortages Issues Medicare Part B Drug Price Issues Expansion of Telehealth Services Vision Research Funding Implementation of No Surprise Act HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act HR 2163/S 464, Safe Step Act HR 1916/S 754, Ensuring Lasting Smiles Act Medicare Coverage for Low Vision Devices HR 4187, the Medicare Vision Act HR 869/S 289, Research Investment to Spark the Economy (RISE) Act HR 366, Protecting Access to Post-COVID 19 Telehealth Act HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 HR 3353, the Contact Lens Prescription Verification Modernization Act HR4122, Resident Education Deferred Interest (REDI) Act HR 5376, the Build Back Better Act HR 6000, Cures 2.0 Act S. 4333, the CLEAR Act S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act
Client expense: $295,000 · Firm income: Not reported
2022 · third_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021" - S 3799 - "PREVENT Pandemics Preparedness Act" - HR 3932/S 2079 - "PASTEUR Act of 2021" - HR 5376 - "Inflation Reduction Act", regarding provisions on prescription drugs - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
2022 · third_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes. S. 1793 / HR 3461 - The Dental and Optometric Care Access Act (DOC Access Act). This will amend title XXVII of the Public Health Service Act to improve health care coverage under vision and dental plans and for other purposes.
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HR 3353 HR3461 S1784
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
HR 3353 HR 3461 Optometric Subjects of Contact Lens Prescription and Vision Plans
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act S. 4293, the Pharmacy Benefit Manager Transparency Act. H.R. _, the Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies Funding Bill Notice Of Proposed Rulemaking (NPRM) On The Affordability Of Employer Coverage For Family Members Of Employees H.R. 7504, the Start-ups for Cures Act H.R. 7505, the More Cures Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation
2022 · second_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes. S. 1793 / HR 3461 - The Dental and Optometric Care Access Act (DOC Access Act). This will amend title XXVII of the Public Health Service Act to improve health care coverage under vision and dental plans and for other purposes.
Client expense: $910,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes.
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
P.L. 111-148 Affordable Care Act, modifications Prior authorization utilization policies Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Medicare Physician Payment Issues HR 315, Medicare Sequester COVID Moratorium Act Drug Pricing and Shortages Issues Medicare Part B Drug Price Issues Expansion of Telehealth Services Vision Research Funding Implementation of No Surprise Act HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act HR 2163/S 464, Safe Step Act HR 1916/S 754, Ensuring Lasting Smiles Act Medicare Coverage for Vision Services Medicare Coverage for Low Vision Devices HR 4187, the Medicare Vision Act Coronavirus Pandemic Relief Measures HR 869/S 289, Research Investment to Spark the Economy (RISE) Act HR 366, Protecting Access to Post-COVID 19 Telehealth Act HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 HR 3353, the Contact Lens Prescription Verification Modernization Act HR4122, Resident Education Deferred Interest (REDI) Act HR 5376, the Build Back Better Act HR 6000, Cures 2.0 Act S. 4333, the CLEAR Act S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act
Client expense: $250,000 · Firm income: Not reported
2022 · second_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HR 3353 HR3461 S1784
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues related to Biden infrastructure plan and associated tax increases Issues related to HHS nominations H.R.4123, Increasing Health Coverage through HRAs Act S.1784/H.R. 3353, the Contact Lens Prescription Verification Modernization Act H.R. 3, the Lower Drug Costs Now Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, legislation to expand access to adult vaccines under Medicare Part B, regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, No PFAS in Cosmetics Act - HR 2467, PFAS Action Act of 2021 - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation - Issues related to FDA review of certain changes to software in medical devices or predetermined change control plans - Issues related to HR ___, "Medical Device User Fee Amendments of 2022"
2022 · first_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes. S. 1793 / HR 3461 - The Dental and Optometric Care Access Act (DOC Access Act). This will amend title XXVII of the Public Health Service Act to improve health care coverage under vision and dental plans and for other purposes.
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Consumer Issues/Safety/Products
Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R. 3353, S. 1784.
Client expense: $260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
P.L. 111-148 Affordable Care Act, modifications Prior authorization utilization policies Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Medicare Physician Payment Issues HR 315, Medicare Sequester COVID Moratorium Act Drug Pricing and Shortages Issues Medicare Part B Drug Price Issues Expansion of Telehealth Services Vision Research Funding Implementation of No Surprise Act HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act HR 2163/S 464, Safe Step Act HR 1916/S 754, Ensuring Lasting Smiles Act Medicare Coverage for Vision Services Medicare Coverage for Low Vision Devices HR 4187, the Medicare Vision Act Coronavirus Pandemic Relief Measures HR 869/S 289, Research Investment to Spark the Economy (RISE) Act HR 366, Protecting Access to Post-COVID 19 Telehealth Act HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 HR 3353, the Contact Lens Prescription Verification Modernization Act HR4122, Resident Education Deferred Interest (REDI) Act HR 5376, the Build Back Better Act HR 6000, Cures 2.0 Act
Client expense: $260,000 · Firm income: Not reported
2022 · first_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Consumer Issues/Safety/Products
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Monitor and outreach related to The Fairness to Contact Lens Consumers Act (Pub. L. 108-164); the Contact Lens Prescription Verification Act (S. 1784, HR 3353). Monitor issues related to telehealth and telemedicine.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
HR 3353 HR3461
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · fourth_quarter · Health Issues
HR 3353 HR3461
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2021 · fourth_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact Lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes. S. 1793 / HR 3461 - The Dental and Optometric Care Access Act (DOC Access Act). This will amend title XXVII of the Public Health Service Act to improve health care coverage under vision and dental plans and for other purposes.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
S. 1784 / HR 3353 - The Contact Lens Prescription Verification Modernization Act. This bill will amend the Fairness to Contact lens Consumers Act to modernize verification of contact lens prescriptions and for other purposes.
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| FL |
| Alan S. Lowenthal | Democratic | CA |
| Albio Sires | Democratic | NJ |
| Alexander X. Mooney | Republican | WV |
| Ann M. Kuster | Democratic | NH |
| Barbara Lee | Democratic | CA |
| Bennie G. Thompson | Democratic | MS |
| Beth Van Duyne | Republican | TX |
| Bill Foster | Democratic | IL |
| Bill Posey | Republican | FL |
| Billy Long | Republican | MO |
| Brian K. Fitzpatrick | Republican | PA |
| Bruce Westerman | Republican | AR |
| Carol D. Miller | Republican | WV |
| Chellie Pingree | Democratic | ME |
| Conor Lamb | Democratic | PA |
| Cynthia Axne | Democratic | IA |
| Darren Soto | Democratic | FL |
| David B. McKinley | Republican | WV |
| David G. Valadao | Republican | CA |
| Debbie Lesko | Republican | AZ |
| Don Bacon | Republican | NE |
| Donald M. Payne, Jr. | Democratic | NJ |
| Elaine G. Luria | Democratic | VA |
| Eric A. "Rick" Crawford | Republican | AR |
| Frank D. Lucas | Republican | OK |
| Grace Meng | Democratic | NY |
| Guy Reschenthaler | Republican | PA |
| Jackie Walorski | Republican | IN |
| Jake LaTurner | Republican | KS |
| James Comer | Republican | KY |
| Jefferson Van Drew | Republican | NJ |
| Jerry L. Carl | Republican | AL |
| Jim Cooper | Democratic | TN |
| Joe Wilson | Republican | SC |
| John A. Yarmuth | Democratic | KY |
| John H. Rutherford | Republican | FL |
| Julia Brownley | Democratic | CA |
| Kurt Schrader | Democratic | OR |
| Lisa Blunt Rochester | Democratic | DE |
| Lloyd Smucker | Republican | PA |
| Mark DeSaulnier | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Michael C. Burgess | Republican | TX |
| Michael Guest | Republican | MS |
| Mike Quigley | Democratic | IL |
| Neal P. Dunn | Republican | FL |
| Norma J. Torres | Democratic | CA |
| Paul Tonko | Democratic | NY |
| Pete Sessions | Republican | TX |
| Raja Krishnamoorthi | Democratic | IL |
| Rodney Davis | Republican | IL |
| Ron Estes | Republican | KS |
| Ron Kind | Democratic | WI |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Sean Casten | Democratic | IL |
| Steve Cohen | Democratic | TN |
| Steve Womack | Republican | AR |
| Steven M. Palazzo | Republican | MS |
| Tom Cole | Republican | OK |
| Tom Malinowski | Democratic | NJ |
| Tom O’Halleran | Democratic | AZ |
| Trent Kelly | Republican | MS |
| Troy Balderson | Republican | OH |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $2,170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,050,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $2,320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE